NeuroSense Therapeutics Ltd. (NRSN) stock
NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.37−0.14 (-9.27%)
Close on Nov 18, 2026Market cap $2.52MP/E –Yield –
NeuroSense Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NeuroSense Therapeutics's enterprise value was $3.04M on Nov 11, 2026, against $28.61M a year earlier. Over the last 5 years it ranged from -$8.24M to $40.52M, with a median of $15.44M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.04M | -83.4% |
| 2025 | Dec 31, 2025 | $18.25M | -10.8% |
| 2024 | Dec 31, 2024 | $20.46M | – |
| 2023 | Dec 29, 2023 | -$6.99M | -313.9% |
| 2022 | Dec 30, 2022 | $3.27M | – |
See a number that looks wrong?